Table 4. Comparison of laboratory and imaging examination results in patients of acute ischemic stroke with or without elevated cTnI.
| cTnI elevation (n = 31) | No cTnI elevation (n = 145) | |
| WBC, ×109/L | 8.46 ± 2.20 | 6.81 ± 2.07* |
| NE | 77.81% ± 11.02% | 66.68% ± 10.38%* |
| AST | 20 (18, 30) | 20 (16, 25) |
| ALT | 15 (10, 23) | 17 (11, 22) |
| LDH | 240 (201, 328) | 178 (151, 227) |
| TC, mmol/L | 3.95 ± 1.30 | 4.38 ± 1.20 |
| TG, mmol/L | 1.85 ± 1.21 | 1.66 ± 1.06 |
| HDL-C, mmol/L | 0.84 ± 0.24 | 1.00 ± 0.27* |
| LDL-C, mmol/L | 2.28 ± 1.00 | 2.66 ± 0.92 |
| CRE, µmol/L | 79.81 ± 13.02 | 68.34 ± 13.79* |
| UA, µmol/L | 332.13 ± 137.22 | 306.39 ± 95.83 |
| UREA, mmol/L | 7.72 (3.84, 10.70) | 4.76 (3.92, 5.82) |
| eGFR, mL/min per 1.73 m2 | 78.88 ± 12.28 | 90.88 ± 19.12* |
| D-D, ng/mL | 322 (215, 545) | 198 (90, 289)* |
| LVEF | 58.32% ± 10.75% | 66.02% ± 8.63%* |
| Infarction site | ||
| Anterior cerebral circulation | 70.9% | 84.8%* |
| Posterior cerebral circulation | 29.1% | 15.2% |
| NIHSS score | 10 (6, 17) | 4 (2, 8)* |
Data were presented as mean ± SD or median (interquartile range). *P < 0.05 indicated statistically significant differences. ALT: alanine aminotransferase; AST: aspartate transaminase; CRE: creatinine; cTnI: cardiac troponin I; D-D: D-dimer; eGFR: estimated glomerular filtration rate; HDL-C: high density lipoprotein cholesterol; LDH: lactate dehydrogenase; LDL-C: low-density lipoprotein cholesterol; LVEF: left ventricular ejection fraction; NE: Neutrophil; NIHSS: NIH Stroke Score; TC: total cholesterol; TG: triglyceride; UA: uric acid; UREA: urea; WBC: White blood cells.